A DOUBLE-BLIND CROSSOVER PILOT-STUDY OF L-DEPRENYL (SELEGILINE) COMBINED WITH CHOLINESTERASE INHIBITOR IN ALZHEIMERS-DISEASE

被引：0
|
作者：
SCHNEIDER, LS [1 ]
OLIN, JT [1 ]
PAWLUCZYK, S [1 ]
机构：
[1] UNIV SO CALIF,SCH MED,DEPT PSYCHIAT & BEHAV SCI,LOS ANGELES,CA 90033
来源：
AMERICAN JOURNAL OF PSYCHIATRY | 1993年 / 150卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
The potential efficacy of oral 1-deprenyl (5 mg b.i.d.) added to the regimen of 10 patients with Alzheimer's disease receiving either tacrine or physostigmine was assessed in a double-blind, placebo-controlled, 4-week, two-period crossover pilot study. 1-Deprenyl was associated with significant improvement in scores on the cognitive subscale of the Alzheimer's Disease Assessment Scale, suggesting possible additive effects of 1-deprenyl to the effects of cholinesterase inhibitors.
引用
收藏
页码：321 / 323
页数：3
相关论文
共 50 条
  • [1] L-DEPRENYL AND PHYSOSTIGMINE FOR THE TREATMENT OF ALZHEIMERS-DISEASE
    MARIN, DB
    BIERER, LM
    LAWLOR, BA
    RYAN, TM
    JACOBSON, R
    SCHMEIDLER, J
    MOHS, RC
    DAVIS, KL
    PSYCHIATRY RESEARCH, 1995, 58 (03) : 181 - 189
  • [2] COGNITIVE EFFECTS OF L-DEPRENYL IN ALZHEIMERS-DISEASE
    TARIOT, PN
    SUNDERLAND, T
    WEINGARTNER, H
    MURPHY, DL
    WELKOWITZ, JA
    THOMPSON, K
    COHEN, RM
    PSYCHOPHARMACOLOGY, 1987, 91 (04) : 489 - 495
  • [3] TRANYLCYPROMINE COMPARED WITH L-DEPRENYL IN ALZHEIMERS-DISEASE
    TARIOT, PN
    SUNDERLAND, T
    COHEN, RM
    NEWHOUSE, PA
    MUELLER, EA
    MURPHY, DL
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1988, 8 (01) : 23 - 27
  • [4] SELEGILINE (L-DEPRENYL) AND L-DOPA TREATMENT OF PARKINSONS-DISEASE - A DOUBLE-BLIND TRIAL
    TAKAHASHI, M
    YUASA, R
    IMAI, T
    TACHIBANA, H
    YORIFUJI, S
    NAKAMURA, Y
    OGAWA, N
    INTERNAL MEDICINE, 1994, 33 (09) : 517 - 524
  • [5] DOUBLE-BLIND PARALLEL DESIGN PILOT-STUDY OF ACETYL LEVOCARNITINE IN PATIENTS WITH ALZHEIMERS-DISEASE
    SANO, M
    BELL, K
    COTE, L
    DOONEIEF, G
    LAWTON, A
    LEGLER, L
    MARDER, K
    NAINI, A
    STERN, Y
    MAYEUX, R
    ARCHIVES OF NEUROLOGY, 1992, 49 (11) : 1137 - 1141
  • [6] COMBINATION L-DEPRENYL AND PHYSOSTIGMINE FOR THE TREATMENT OF ALZHEIMERS-DISEASE
    MARIN, D
    BIERER, L
    LAWLOR, B
    RYAN, T
    MARKOFSKY, R
    WILLIAMS, L
    DAVIS, K
    BIOLOGICAL PSYCHIATRY, 1993, 33 (6A) : A141 - A141
  • [7] A DOUBLE-BLIND PARALLEL DESIGN PILOT-STUDY WITH ACETYL-L-CARNITINE IN PATIENTS WITH PROBABLE ALZHEIMERS-DISEASE
    SANO, M
    BELL, K
    COTE, L
    DOONEIEF, G
    LEGLER, L
    LAWTON, A
    MARDER, K
    REBISCHUNG, D
    STERN, Y
    MAYEUX, R
    ANNALS OF NEUROLOGY, 1991, 30 (02) : 285 - 285
  • [8] LONG-TERM, DOUBLE-BLIND TRIAL OF SELEGILINE IN ALZHEIMERS-DISEASE
    RIEKKINEN, PJ
    KOIVISTO, K
    HELKALA, EL
    HANNINEN, T
    VANHANEN, M
    AALTONEN, H
    KILKKU, O
    HEINONEN, E
    NEUROBIOLOGY OF AGING, 1994, 15 : S67 - S67
  • [9] COMBINATION OF TACRINE ANS SELEGILINE IN ALZHEIMERS-DISEASE - AN OPEN PILOT-STUDY
    ALHAINEN, K
    NEUROBIOLOGY OF AGING, 1994, 15 : S136 - S136
  • [10] A DOUBLE-BLIND PLACEBO STUDY OF L-DEPRENYL IN AFFECTIVE-DISORDERS
    MENDLEWICZ, J
    YOUDIM, MBH
    PSYCHOPHARMACOLOGY BULLETIN, 1983, 19 (03) : 328 - 332
12345